GE's $100M cancer challenge kicks its idea machine into motion

GE Healthcare says it will carve out a billion dollars from its research budget over the next 5 years to support work on new cancer detection and treatment technologies and joined with a group of venture companies to back a $100 million "open innovation" challenge to spur new scientific work. And their website has already begun to attract some interesting proposals. Their initial focus: The lethal triple negative form of breast cancer.

To get the idea machine rolling, GE has hosted a website that is posting pitches. New proposals range from projects on epigenetic treatments now in animal studies to ideas on cloud computing and new diagnostics for detecting a recurring case of cancer. When GE offered a similar proposal on clean tech, it drew more than 5,000 ideas that led to $134 million in investments for programs and partnerships. New cancer submissions will be taken through November 20.

GE is also creating a "super database" to consolidate clinical, pathology, therapy and outcomes data from its medical quality improvement consortium. GE and O'Reilly Media plan to host a series of "code-a-thons" which will be aimed at the data science field as they look for new applications for existing cancer data.

- read the GE release
- here's the AFP story

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.